ConductScience.org, home

Paper36095166

The Tumor Microenvironment of Clear-Cell Ovarian Cancer.

Devlin MJ and 9 others. Cancer Immunol Res, 2022. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. The Tumor Microenvironment of Clear-Cell Ovarian Cancer. Papers, record 36095166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36095166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Tumor Microenvironment of Clear-Cell Ovarian Cancer.
PubMed
Journal
Cancer Immunol Res
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
2.77
iCite
Revised in PubMed
2026-10-31
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tumor MicroenvironmentMajor topic
Ovarian NeoplasmsMajor topic
Female
Humans
Programmed Cell Death 1 Receptor
CD8-Positive T-Lymphocytes
Collagen

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
C16420/A18066Cancer Research UKUnited KingdomPubMed
C355/A25137Cancer Research UKUnited KingdomPubMed
MR/S00629×1Medical Research CouncilUnited KingdomPubMed
MR/S00629X/1Medical Research CouncilUnited KingdomPubMed
A16354Cancer Research UKUnited KingdomPubMed
A25714Cancer Research UKUnited KingdomPubMed
25714Cancer Research UKUnited KingdomPubMed
G-MGU0418Wellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133504622A FIJI macro for quantifying pattern in extracellular matrix.Life Sci Alliance2021https://conductscience.org/library/papers/33504622PubMed
225428504Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.Nature2014https://conductscience.org/library/papers/25428504PubMed
327475412Immune-inflammation gene signatures in endometriosis patients.Fertil Steril2016https://conductscience.org/library/papers/27475412PubMed
417007852Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis.Fertil Steril2006https://conductscience.org/library/papers/17007852PubMed
531311810HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer.Cancer Res2019https://conductscience.org/library/papers/31311810PubMed
630410077TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure.Nat Commun2018https://conductscience.org/library/papers/30410077PubMed
728266140Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma.Cancer Sci2017https://conductscience.org/library/papers/28266140PubMed
828796747Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma.Int J Gynecol Pathol2018https://conductscience.org/library/papers/28796747PubMed
920942669ARID1A mutations in endometriosis-associated ovarian carcinomas.N Engl J Med2010https://conductscience.org/library/papers/20942669PubMed
1031046082Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study.Ann Oncol2019https://conductscience.org/library/papers/31046082PubMed
1127536203The association between interleukin-4 -590C/T genetic polymorphism, IL-4 serum level, and advanced endometriosis.Cent Eur J Immunol2016https://conductscience.org/library/papers/27536203PubMed
1231519915B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma.Nat Commun2019https://conductscience.org/library/papers/31519915PubMed
1322159717The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.Mol Cell Proteomics2012https://conductscience.org/library/papers/22159717PubMed
1419892717Role of TGF-betas in normal human endometrium and endometriosis.Hum Reprod2010https://conductscience.org/library/papers/19892717PubMed
1526087191COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization.Oncotarget2015https://conductscience.org/library/papers/26087191PubMed
1631339433Interactions between TGF-β type I receptor and hypoxia-inducible factor-α mediates a synergistic crosstalk leading to poor prognosis for patients with clear cell renal cell carcinoma.Cell Cycle2019https://conductscience.org/library/papers/31339433PubMed
1729575153Validation of the systematic scoring of immunohistochemically stained tumour tissue microarrays using QuPath digital image analysis.Histopathology2018https://conductscience.org/library/papers/29575153PubMed
1816642009GenePattern 2.0.Nat Genet2006https://conductscience.org/library/papers/16642009PubMed
1931869309IL-2 and IL-27 synergistically promote growth and invasion of endometriotic stromal cells by maintaining the balance of IFN-γ and IL-10 in endometriosis.Reproduction2020https://conductscience.org/library/papers/31869309PubMed
2017640886Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17640886PubMed

See all 48 referencesDownload CSV of references

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
42984928Immunotherapy in Advanced Epithelial Ovarian Cancer: Successes and Frustrations.Oncol Res2026https://conductscience.org/library/papers/42984928PubMed
42721374Profiling tumor immune microenvironment of epithelial ovarian carcinoma.Oncoimmunology2026https://conductscience.org/library/papers/42721374PubMed
42420312Spatial transcriptomic profiling of ovarian clear cell carcinoma reveals heterogeneity in OXPHOS and EMT gradients.Nat Commun2026https://conductscience.org/library/papers/42420312PubMed
42129168Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial.Nat Commun2026https://conductscience.org/library/papers/42129168PubMed
41994332Matrix structure and microenvironment dynamics correlate with chemotherapy response in ovarian cancer.iScience2026https://conductscience.org/library/papers/41994332PubMed
41969482Analysis of prognostic factors in ovarian clear cell carcinoma: a retrospective cohort study.Transl Cancer Res2026https://conductscience.org/library/papers/41969482PubMed
41883867Molecular profile and targeted therapies for ovarian clear cell ovarian cancer.Ther Adv Med Oncol2026https://conductscience.org/library/papers/41883867PubMed
41723536Distinct immune microenvironments in ovarian cancer subtypes indicate potential for immunotherapies.J Transl Med2026https://conductscience.org/library/papers/41723536PubMed
41634757Role of immune cells in clear cell ovarian cancer: a two-sample bidirectional Mendelian randomization study.J Ovarian Res2026https://conductscience.org/library/papers/41634757PubMed
41383608The immunotherapy era in ovarian clear cell carcinoma: current evidence and future perspective.Front Immunol2025https://conductscience.org/library/papers/41383608PubMed
41020848Tumor Immune Microenvironment and Checkpoint Inhibition in Clear Cell Ovarian Carcinoma: Bridging Tumor Biology and Clinical Application in Immunotherapy.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41020848PubMed
40948537Enhanced prognostic stratification in early-stage epithelial ovarian cancer: multi-histological analysis of neutrophil-to-lymphocyte ratio with particular emphasis on clear cell histology.Am J Cancer Res2025https://conductscience.org/library/papers/40948537PubMed
40705396Durvalumab versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial.Clin Cancer Res2025https://conductscience.org/library/papers/40705396PubMed
40382714Effectiveness and safety of pembrolizumab for the treatment of Japanese patients with microsatellite instability-high tumors excluding colorectal cancer: a post-marketing surveillance.Jpn J Clin Oncol2025https://conductscience.org/library/papers/40382714PubMed
39608974Genetic and therapeutic heterogeneity shape the baseline and longitudinal immune ecosystem of ovarian clear cell carcinoma.J Immunother Cancer2024https://conductscience.org/library/papers/39608974PubMed
38929687Genetic Links between Endometriosis and Endometriosis-Associated Ovarian Cancer-A Narrative Review (Endometriosis-Associated Cancer).Life (Basel)2024https://conductscience.org/library/papers/38929687PubMed
38886573The importance of 3D fibre architecture in cancer and implications for biomaterial model design.Nat Rev Cancer2024https://conductscience.org/library/papers/38886573PubMed
38847966Efficacy of immunotherapy in ARID1A-mutant solid tumors: a single-center retrospective study.Discov Oncol2024https://conductscience.org/library/papers/38847966PubMed
38492450Targeting the immune microenvironment in ovarian cancer therapy-mission impossible?ESMO Open2024https://conductscience.org/library/papers/38492450PubMed
38410204Developing and validating the model of tumor-infiltrating immune cell to predict survival in patients receiving radiation therapy for head and neck squamous cell carcinoma.Transl Cancer Res2024https://conductscience.org/library/papers/38410204PubMed

See all 31 cited byDownload CSV of cited by

Genes30

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB610058PubTator's text mininghttps://conductscience.org/library/genes/10058NCBI Gene
ACTA158PubTator's text mininghttps://conductscience.org/library/genes/58NCBI Gene
ACTA259PubTator's text mininghttps://conductscience.org/library/genes/59NCBI Gene
ARID1A8289PubTator's text mininghttps://conductscience.org/library/genes/8289NCBI Gene
CD1639332PubTator's text mininghttps://conductscience.org/library/genes/9332NCBI Gene
CD1A909PubTator's text mininghttps://conductscience.org/library/genes/909NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CEACAM81088PubTator's text mininghttps://conductscience.org/library/genes/1088NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL12B3593PubTator's text mininghttps://conductscience.org/library/genes/3593NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
IL43565PubTator's text mininghttps://conductscience.org/library/genes/3565NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
KRT2054474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene
MSH24436PubTator's text mininghttps://conductscience.org/library/genes/4436NCBI Gene

See all 30 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36095166

GET https://conductscience.org/api/papers/v1/36095166/references?page=2